Meso Numismatics, Inc. provided earnings guidance for the fiscal year 2024. The company expects to reach $5 million in revenues with approximately $1 million in operating profits (defined as gross profit less total operating expenses) for its fiscal year 2024. Although overall sales are expected to increase, the significant sales increase is expected to come from the patient procedure category as the Company?s Cancun based clinic starts to increase the total number of monthly patient procedures.
Regenerative Medical Technology Group Inc.
Equities
MSSV
US59071L1035
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0425 USD | -3.91% |
|
+21.43% | +482.19% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+482.19% | 531K | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- MSSV Stock
- News Regenerative Medical Technology Group Inc.
- Meso Numismatics, Inc. Provides Earnings Guidance for the Fiscal Year 2024